ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
다우존스 지수
44,296.51
0.97%
Bitcoin
98,656.02
-0.38%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Abeona Therapeutics Inc (ABEO)

  7. Abeona Therapeutics Inc (ABEO) 뉴스

Abeona Therapeutics Inc

Abeona Therapeutics Inc (ABEO)

ABEO SA
5.98
0.19
(3.28%)
마감 23 11월 6:00AM
15분 지연
5.91
-0.07
(-1.17%)
시간외 거래: 9:10AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

ABEO 뉴스

공식 뉴스 전용

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
14 11월 2024
ABEO (3.28%)

Form 8-K - Current report
Edgar (US Regulatory)
14 11월 2024
ABEO (3.28%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
13 11월 2024
ABEO (3.28%)

Form 8-K - Current report
Edgar (US Regulatory)
29 10월 2024
ABEO (3.28%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 10월 2024
ABEO (3.28%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
01 10월 2024
ABEO (3.28%)

ABEO Discussion

게시물 보기
Monksdream Monksdream 3 월 전
ABEO under $7

👍️0
Monksdream Monksdream 3 월 전
ABEO under $6
👍️0
Monksdream Monksdream 7 월 전
ABEO under $5
👍️0
Awl416 Awl416 7 월 전
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
👍️0
Monksdream Monksdream 9 월 전
ABEO new 52+week high
👍️0
Monksdream Monksdream 9 월 전
ABEO new 52 week high
👍️0
Monksdream Monksdream 9 월 전
ABEO new 52 week high
👍️0
Monksdream Monksdream 9 월 전
ABEO new 52 week high
👍️0
Monksdream Monksdream 9 월 전
ABEO new 52 week high
👍️0
Monksdream Monksdream 9 월 전
ABEO new 52 week high
👍️0
Joelzee Joelzee 1 년 전
Of course this goes up after I close my position. ??
👍️0
Invest-in-America Invest-in-America 2 년 전
You gots me CONFUSED, Young Lady!! YES, I indeed DID post over there --- which YOU should have IGNORED in the first place!! WHATEVER!!! Bottom line???? GO-GO-GO-BABL and HPCO!!! Those two are where I am 'losing-my-shirt' right now!!

👍️0
gail gail 2 년 전
you already posted there silly, so i replied to you there in pm. and yes, i know you cant pm back anymore.
👍️0
Invest-in-America Invest-in-America 2 년 전
O.K., I'll take a look at THAT one right now.
👍️0
gail gail 2 년 전
i found it on my…

..

own but got back out, its junk, lol. i was replying to you on the other stock admp.
👍️0
Invest-in-America Invest-in-America 2 년 전
ABEO: It's pronounced like, "ABALONE" (that Fish thing)!!

PS: I got your PM, but can't reply to it. Bottom line, do NOT "invest" in ANY of my stock picks!! (Which is great advice for ME, too!!)

👍️0
gail gail 2 년 전
can anyone pronounce …

..

this?

Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
👍️0
gail gail 2 년 전
nice pop in overnight trading. lets see what she does today.
👍️0
gail gail 2 년 전
quiet board but this stock is on the move! grabbed a few today.
👍️0
stock1ace1 stock1ace1 2 년 전
$3.69 news data coming within a month
👍️0
stock1ace1 stock1ace1 2 년 전
Topline data from the Phase 3 VIITAL™ study of EB-101 in RDEB is on track for late third quarter to early fourth quarter of 2022 upon completion of the last patient monitoring visit, which is expected by mid-September.
👍️0
stock1ace1 stock1ace1 2 년 전
Buying $3.01 phase 3 data due anyday 3 mil o/s 3 mill float



Topline data from the Phase 3 VIITAL™ study of EB-101 in RDEB is on track for late third quarter to early fourth quarter of 2022 upon completion of the last patient monitoring visit, which is expected by mid-September.
👍️0
INFINITI INFINITI 2 년 전
We need to get this over $1
👍️0
INFINITI INFINITI 2 년 전
Let’s goooo$$$$
👍️0
INFINITI INFINITI 2 년 전
Looks good here
👍️0
saj saj 3 년 전
ABEO .35 +7%
👍️0
ClayTrader ClayTrader 4 년 전
* * $ABEO Video Chart 02-25-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
jerseyboy jerseyboy 4 년 전
They are MBIO, SIOX, and GTHX. GTHX will be the most successful of the three, as they have a recently-approved drug that will change the face of the use of chemotherapy. It is still amazingly cheap relative to its value, and is an easy three-bagger within at most two years, and probably before that.
👍️0
CyrusDaVirus CyrusDaVirus 4 년 전
Which are those 3?
👍️0
jerseyboy jerseyboy 4 년 전
I had to say goodbye to Abeona earlier this week when its price rose above my basis, as I swore to myself that I would do so if it ever recovered from its rapid decline to $1.00. I split it among three other biopharmas which I think have more immediate prospects of bringing their pipelines to revenue-generating fruition. This is a good company, but I think bringing their pipeline to revenue-generating fruition will take awhile from this point. Michael Amoroso should get a lot of credit for what he's done so far as Abeona's leader. Good luck to all who invest here. You could find a lot worse companies in which to invest.
👍️0
jerseyboy jerseyboy 4 년 전
I like what they're doing and obviously also like the share price movement today. Michael Amoroso should get a lot of credit for the way he was able to turn this situation around.
👍️0
jerseyboy jerseyboy 4 년 전
Apparently from the news today Michael Amoroso does know what he is doing. I had a feeling that they were down but not out. I have a good feeling about the gradual and successful development of their pipeline.
👍️0
Golden Cross Golden Cross 4 년 전
Heck ya
👍️0
jerseyboy jerseyboy 4 년 전
The share price is certainly showing a nice steady increase.
👍️0
Golden Cross Golden Cross 4 년 전
Chart looks to be a nice steady incline here
👍️0
jerseyboy jerseyboy 4 년 전
With today's advance, this has almost doubled from the level to where it fell when the CEO and five directors simultaneously resigned. Hopefully the price advance reflects positive things that Michael Amoroso is doing to develop the company. I've held all my shares through the downturn, and have confidence in his background and the company's pipeline.
👍️0
Golden Cross Golden Cross 4 년 전
strong chart here
👍️0
jerseyboy jerseyboy 4 년 전
I feel like people are sleeping on this one. It was a major shock from which to recover to have the CEO and half of the board resign, but I think Michael Amoroso knows what he is doing and is doing a good job in moving the company forward, and I believe that there is good long-term potential here.
👍️0
railrider railrider 4 년 전
News just out spiking up on it
👍️0
jerseyboy jerseyboy 4 년 전
Wow - nice jump today - up 17%! It's still a long way to my basis of $2.98 per share, but something is afoot here with the kind of volume we saw today.
👍️0
jerseyboy jerseyboy 4 년 전
Nice jump today and up over 50% from its low. Let's hope Michael Amoroso can do something here with the assets and the pipeline. He's certainly got the background to be able to bring it forward.
👍️0
ClayTrader ClayTrader 4 년 전
* * $ABEO Video Chart 11-11-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 4 년 전
Breaking News: $ABEO What Are The Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch

3 Biotech Penny Stocks to Watch in 2020 Biotech penny stocks have become some of the most popular choices for all types of investors. Both institutional and retail investors have been working to seek gains in the biotech industry. Since the beginning of the year, investors have turn...

Got this from ABEO - What Are The Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch
👍️0
realfast95 realfast95 4 년 전
2x813008 shares free options for 1 year, to two directors
WTF
👍️0
realfast95 realfast95 4 년 전
On September 17, 2020, Abeona Therapeutics Inc. (the “Company”) had filed a Current Report on Form 8-K reporting that Steven H. Rouhandeh had notified the Company of his resignation from the Board of Directors (the “Board”), effective September 30, 2020. On September 30, 2020, Mr. Rouhandeh rescinded his resignation from the Board, and the Board accepted his rescission of resignation. Also on September 30, 2020, the Board voted unanimously to elect Mr. Rouhandeh as Chairman of the Board. Mr. Rouhandeh will not be taking on any additional compensation as Chairman other than what he was already receiving as a non-employee director, which such compensation is disclosed in the Company’s proxy statement filed on April 10, 2020.

8k
👍️0
whytestocks whytestocks 4 년 전
BREAKING NEWS: $ABEO Abeona Therapeutics' Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership Plan

Steven H. Rouhandeh Appointed as Chairman of the Board of Directors Jefferies LLC R etained as F inancial A dvisor to A ssist with the R eview of S trategic O ptions NEW YORK and CLEVELAND, Oct. 06, 2020 (GLOBE NEWSWI...

Find out more ABEO - Abeona Therapeutics' Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership Plan
👍️0
realfast95 realfast95 4 년 전
Steven Rouhandeh
Founder,Chairman and Chief Investment Officer at SCO Capital Partners
Location: United States

Mr. Steven H. Rouhandeh, also known as Steve, J.D., is the Founder of SCO Capital Partners, LLC and has been its Chairman and Chief Investment Officer since 1997. Mr. Rouhandeh is the Founder of SCO Financial Group, LLC and serves as its Chairman. He has been an Executive Chairman at PlasmaTech Biopharmaceuticals, Inc. since March 4, 2008 and has been its Principal Executive Officer since January 1, 2015.
👍️0
realfast95 realfast95 4 년 전

Abeona Therapeutics’ Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Lead...
October 06 2020 - 04:01PM

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that its Board of Directors has formed a Special Committee to oversee and advise the executive leadership team on the operations of the Company, leveraging the respective medical, business development and financial expertise of its members. The Special Committee, which consists of current board members, is also working closely with the executive leadership team to develop the Company’s strategic direction and leadership plan as it continues to advance its clinical programs toward providing novel gene and cell therapies to patients who currently have no approved treatment options. The Company also announced the appointment of Steven H. Rouhandeh as Chairman of its Board of Directors.

Strategic Review

Abeona has retained Jefferies LLC as its financial advisor to assist with the review of strategic options focused on advancing the Company’s mission and maximizing stakeholder value. There can be no assurance this strategic review will result in the completion of any particular course of action. There is no defined timeline for completion of the review process and the Company does not intend to comment further unless a specific initiative is approved by the Board of Directors, the review process is concluded, or it is otherwise determined that other disclosure is appropriate.
👍️0
realfast95 realfast95 4 년 전
Abeona Therapeutics selloff yesterday an overreaction, says B. Riley FBR 08:00 ABEO B. Riley FBR analyst Justin Zelin lowered the firm's price target on Abeona Therapeutics to $2 from $5 and reiterates a Buy rating on the shares. The company's assets, including manufacturing infrastructure, are worth more than the market's current valuation following yesterday's 41% selloff, Zelin tells investors in a research note. However, to reflect reduced transparency into Abeona's leadership and strategy Zelin lowered his probability of success for lead asset EB-101 from 65% to 50% and from 20% to 15% for AB-102 and AB-101. Nonetheless, the analyst views yesterday's pullback as overreaction and continues to see upside in the shares.

Read more at:
https://thefly.com/n.php?id=3167175
👍️0
RJ Trotts RJ Trotts 4 년 전
picked up some shares for a bounce here
👍️0

최근 히스토리

NASDAQ
ABEO
Abeona Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유